Medicine and Dentistry
Genetic Risk
100%
Maturity Onset Diabetes of the Young
85%
Blood Pressure
73%
Diseases
51%
Cesarean Section
43%
Patient with Type 2 Diabetes
43%
Genome Wide Association Study
42%
Ischemic Heart Disease
36%
Birth Weight
36%
Coronary Angiography
36%
Metabolite
36%
Single Nucleotide Polymorphism
36%
Vaginal Delivery
36%
Logistic Regression Analysis
36%
Coronary Vessel
36%
Placenta
36%
Glucagon Like Peptide 1
36%
Prenatal Growth
36%
Hyperglycemia
36%
Placenta Accreta
36%
Pregnancy
36%
Arterial Wall Thickening
36%
Pleiotropy
36%
Myometrium
36%
Pharmacogenetics
36%
Disease Exacerbation
29%
Dystocia
29%
Glucagon-Like Peptide-1 Agonist
27%
Body Mass Index
24%
Prenatal Diagnosis
18%
Phenylalanine
18%
Dose Response
18%
Odds Ratio
18%
Allele
18%
Echography
18%
Scar Formation
18%
Valine
18%
Fetus Growth
18%
Umbilical Cord
18%
Intima-Media Thickness
18%
Insulin Resistance
18%
Hyperlipidemia
18%
Apgar Score
18%
Keyphrases
Genetic Risk Score
71%
Weight Maintenance
56%
Type 2 Diabetes Mellitus (T2DM)
56%
Weight Loss
49%
Type 2 Diabetic Patients
45%
Liraglutide
43%
Cardiovascular Disease
36%
Voltage-gated Potassium Channel
36%
Pharmacogenetics
36%
Incretin
36%
Placenta Accreta
36%
Genetic Determinants
36%
Plaque Formation
36%
GLP-1 Analogue
36%
Blood Pressure
36%
Apolipoprotein B (Apo B)
36%
Disease Progression
36%
Ether
36%
Birth Weight
36%
KCNH2
36%
Response to Treatment
36%
Hyperglycemia
36%
Individual Response
36%
Amino Acid Content
36%
Combined Delivery
36%
Glucagon
36%
Intrauterine Growth
36%
Branched-chain Amino Acids
36%
Common Variants
36%
Week of Gestation
36%
Glucagon-like
34%
Glucose-dependent Insulinotropic Polypeptide
24%
A1 Receptor
21%
Receptor Agonist
21%
Coronary Vessel Disease
18%
Uterine Scarring
18%
Carotid Intima-media Thickness (cIMT)
18%
Uterine Contractility
18%
Large VLDL
18%
Antidiabetic Treatment
18%
Type 2 Diabetes Risk
16%
Insulin
16%
Genetic Variants
15%
Biochemistry, Genetics and Molecular Biology
Genetic Risk
77%
Triglyceride
64%
Allele
59%
Lipid
57%
Glucagon-Like Peptide-1
50%
Blood Plasma
47%
Liraglutide
43%
Metabolite
39%
Genotyping
39%
Pharmacogenetics
36%
Blood Pressure
36%
Genetic Divergence
36%
Incretin
36%
Hyperglycemia
36%
Apolipoprotein B
36%
Single Nucleotide Polymorphism
36%
Glucagon
36%
Pleiotropy
36%
Amino Acid
36%
Genome Wide Association Study
36%
Voltage-Gated Potassium Channel
36%
TCF7L2
36%
Triglyceride-Rich Lipoprotein
36%
Gastric Inhibitory Polypeptide
27%
QT Interval
22%
Blood Level
22%
Receptor Agonists
21%
Glucagon-Like Peptide 1 Receptor
21%
CYP2C9
18%
Dose Response
18%
Human Genetics
18%
ABCC8
18%
Hyperlipidemia
18%
